Abstract：Objective: To observe the clinical effect of Shenmai injection on tumor necrosis factor-alpha(TNF-α), IL-1β, IL-6, IL-10 in patients with severe pneumonia.Methods: A total of 60 patients with severe pneumonia were divided into routine group (n=30) and observation group (n=30). Patients in the routine group were in routine therapy. Treatment of routine therapy combined with Shenmai injection was applied in the observation group. The clinical effect and the levels of TNF-α, IL-1β, IL-6, IL-10 were compared between the two groups. Results: The effective rate was higher in observation group than that of the routine group (P<0.05). The levels of TNF-α, IL-1β,IL-6 decreased significantly and the level of IL-10 increased after the treatment (P<0.05). The levels of TNF-α, IL-1β,IL-6 were significantly lower than those in the control group, while the level of IL-10 was significantly higher than that in the control group (P<0.05). Conclusion: Treatment of routine therapy combined with Shenmai injection for severe pneumonia has certain clinical application value.
范晓春,屠苏. 参麦注射液对重症肺炎患者炎症因子影响[J]. 河北医学, 2018, 24(10): 1656-1658.
FAN Xiaochun, TU Su, CAO Futao. Effect of Shenmai Injection on Inflammatory Factors in Patients with Severe Pneumonia. HeBei Med, 2018, 24(10): 1656-1658.
[1] Sibila O,Meduri GU ,Mortensen EM .et al. Improving the 2007 infectious disease society of America/American thoracic society severe community-acquired pneumonia criteria to predict intensive care unit admission[J].Crit Care, 2013, 28(3):284~290. [2] 轩静静,高彩霞,关怀敏.参麦注射液治疗急性心肌梗死后心力衰竭患者的远期临床疗效[J].中成药,2015,9(8):266~267. [3] Mandell L A, Wunderink R G, Anzueto A, et al.Infectious diseases society of American／American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults[J].Clin Infect Dis, 2007, 44(Suppl 2 )S27~72. [4] 肖建国,宋青,黎檀实.脓毒症细菌内毒素诱导血管内皮细胞损伤与Toll样受体和钙信号的相关性研究[J].中华危重病急救医学,2017,29(2):150~155. [5] 张孝钦,严建平.参麦注射液辅助治疗重症肺炎的临床观察[J].中国中医药科技,2014,21(2):183~184. [6] 马月霞,李倩,王玉光.利巴韦林注射液与参麦注射液单用及联合应用对甲型H1N1流感小鼠重症肺炎的疗效研究[J].世界中医药,2014,9(8):1055~1057. [7] 黄璟,周毅.肿瘤坏死因子α及其抑制剂的研究进展[J].国际口腔医学杂志,2015,42(1):63~68. [8] 李瑞,李丹,刘囡.创伤性脑损伤后白细胞介素1β在星形胶质细胞中的表达[J].解剖学杂志,2016,39(3):324~326. [9] 韩利,张筠,张铁栓.重症肺炎患者D-二聚体、纤维蛋白原、IL-6水平变化及其临床意义[J].中国呼吸与危重监护杂志,2017(1):71~73. [10] HUNTER C A,JONES S A .IL-6 as a keystone cytokine in health and disease[J].Nat Immunol ,2015,16(5):448~457. [11] 李树青,孙雪丽,王执勇.乌司他丁对重症肺炎患儿血清TNF-αIL-6IL-8IL-10水平的影响[J].中国急救医学,2016,36(10):940~942.
2018, Vol. 24 
冀公网安备13080202000677号